
Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated July 02, 2021, titled "Restoration of CEP for Ranitidine Hydrochloride Drug Substance granted by EDQM.".
Filed with NSE ·

Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated July 02, 2021, titled "Restoration of CEP for Ranitidine Hydrochloride Drug Substance granted by EDQM.".
6ix hasn’t read this filing yet.
Solara Active Pharma Sciences Ltd. on 6ix
Follow Solara Active Pharma Sciences into a list and get an email when it puts out news.
Follow Solara Active Pharma Sciences